Acorda Therapeutics, Inc. Stock Split Ratio
Acorda Therapeutics, Inc. reported Stock Split Ratio of 5.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-04-01
- Acorda Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2023 was 5.00%.
- Acorda Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 16.70%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|
| 2023-12-31 | 5.00% 10-K · filed 2024-04-01 |
| 2020-12-31 | 16.70% 10-K · filed 2023-03-15 |